Cancer Treatment and End-of-Life Care
(2018) In Journal of Palliative Medicine 21(8). p.1100-1106- Abstract
AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.
PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.
RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30... (More)
AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.
PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.
RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.
CONCLUSIONS: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).
(Less)
- author
- Sinha, Sudha ; Matharu, Jaskirt Kaur ; Jacob, Jean ; Palat, Gayatri ; Brun, Eva LU ; Wiebe, Thomas LU and Segerlantz, Mikael LU
- organization
-
- Head and Neck Cancer Research Group (research group)
- Tumor microenvironment
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Late effects after childhood cancer treatment (research group)
- Paediatrics (Lund)
- The Institute for Palliative Care (research group)
- Palliative care
- publishing date
- 2018-08
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Palliative Medicine
- volume
- 21
- issue
- 8
- pages
- 1100 - 1106
- publisher
- Mary Ann Liebert, Inc.
- external identifiers
-
- pmid:29768074
- scopus:85050626973
- ISSN
- 1096-6218
- DOI
- 10.1089/jpm.2017.0695
- language
- English
- LU publication?
- yes
- id
- d84c5991-32c6-4898-8733-093841a17160
- date added to LUP
- 2019-07-01 14:00:31
- date last changed
- 2024-10-02 08:39:41
@article{d84c5991-32c6-4898-8733-093841a17160, abstract = {{<p>AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.</p><p>PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.</p><p>RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.</p><p>CONCLUSIONS: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).</p>}}, author = {{Sinha, Sudha and Matharu, Jaskirt Kaur and Jacob, Jean and Palat, Gayatri and Brun, Eva and Wiebe, Thomas and Segerlantz, Mikael}}, issn = {{1096-6218}}, language = {{eng}}, number = {{8}}, pages = {{1100--1106}}, publisher = {{Mary Ann Liebert, Inc.}}, series = {{Journal of Palliative Medicine}}, title = {{Cancer Treatment and End-of-Life Care}}, url = {{http://dx.doi.org/10.1089/jpm.2017.0695}}, doi = {{10.1089/jpm.2017.0695}}, volume = {{21}}, year = {{2018}}, }